Anika Therapeutics, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Anika Therapeutics, Inc. (ANIK) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $310.00 thousand for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-01.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2016-11-01
- Anika Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2016-09-30 was $310.00K, a 19.23% increase year-over-year.
- Anika Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2016-06-30 was -$536.00K, a 228.54% decline year-over-year.
- Anika Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2015-09-30 was $260.00K.
- Anika Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2015-06-30 was $417.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month as first filed |
|---|---|---|---|---|---|---|
| 2016-09-30 | $310.00K 10-Q · filed 2016-11-01 | -$226.00K derived: sum of 2 quarters · filed 2016-11-01 | $548.00K 10-Q · filed 2016-11-01 | |||
| 2016-06-30 | -$536.00K 10-Q · filed 2016-08-01 | $238.00K 10-Q · filed 2016-08-01 | ||||
| 2015-09-30 | $260.00K 10-Q · filed 2016-11-01 | $259.81K 10-Q · filed 2015-11-03 | $677.00K derived: sum of 2 quarters · filed 2016-11-01 | -$1.57M 10-Q · filed 2016-11-01 | -$1.57M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $417.00K 10-Q · filed 2016-08-01 | $417.49K 10-Q · filed 2015-08-04 | -$1.83M 10-Q · filed 2016-08-01 | -$1.83M 10-Q · filed 2015-08-04 | ||
| 2014-09-30 | -$1.68M 10-Q · filed 2015-11-03 | -$1.87M derived: sum of 2 quarters · filed 2015-11-03 | -$1.90M 10-Q · filed 2015-11-03 | |||
| 2014-06-30 | -$190.74K 10-Q · filed 2015-08-04 | -$216.85K 10-Q · filed 2015-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |